[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338678-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338678-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lung-cancer-screening-in-india-preparing-for-the-future-using-smart-tools-biomarkers-to-identify-highest-risk-individuals","Lung cancer screening in India: Preparing for the future using smart tools & biomarkers to identify highest risk individuals","","Growing lung cancer burden in India is projected to rise markedly over the coming decade, with most patients presenting at advanced, incurable stages and facing substantial annual mortality. Annual low-dose computerized tomography remains the standard screening approach, yet resource constraints make broad implementation difficult. The review examines India-specific epidemiology, links disease patterns to smoking and environmental pollution, and evaluates how smart tools using demographic and genomic data alongside blood-based biomarkers could help identify the highest-risk individuals and enable a more efficient screening program, while addressing key operational challenges.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lung-cancer-screening-in-india-preparing-for-the-future-using-smart-tools-biomarkers-to-identify-highest-risk-individuals/338678/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lung-cancer-screening-in-india-preparing-for-the-future-using-smart-tools-biomarkers-to-identify-highest-risk-individuals/338678.png","ImageObject",300,407,{"name":42,"@type":43},"Valentina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is lung cancer screening important in India?","Question",{"text":63,"@type":64},"Most patients in India present with advanced disease and have high mortality. Early detection through lung cancer screening can enable curative therapy for earlier stages and improve survival.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the standard method for lung cancer screening mentioned in the review?",{"text":68,"@type":64},"Annual low-dose computerized tomography (LDCT) is described as the standard method for lung cancer screening.",{"name":70,"@type":61,"acceptedAnswer":71},"How can smart tools and biomarkers improve lung cancer screening?",{"text":72,"@type":64},"The review suggests that leveraging demographic and genomic data, using smart tools, and applying blood-based biomarkers could help identify individuals at highest risk and make screening programs more efficient in resource-limited settings.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338678,1790196802,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Indian J Med Res 160, December 2024, pp 561-569 DOI: 10.25259/ijmr_ 118_24  \nReview Article  \nLung cancer screening in India: Preparing for the future using smart tools & biomarkers to identify highest risk individuals  \nNithya Ramnath1, Prasanth Ganesan2, Prasanth Penumadu3, Douglas Arenberg1 & Alex Bryant1  \n1Department of Internal Medicine, University of Michigan, United States, 2Department of Medical Oncology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, & 3Department of Surgical Oncology, Sri Venkateswara Institute of Cancer Care & Advanced Research, Tirupati, India  \nReceived March 09, 2024; Accepted August 23, 2024; Ahead of print January 15, 2025; Published January 22, 2025  \nThere is a growing burden of lung cancer cases in India, incidence projected to increase from 63,708  \ncases (2015) to 81,219 cases (2025). The increasing numbers are attributed to smoking (India currently  \nhas nearly 100 million adult smokers) and environmental pollution. Most patients present with advanced  \ndisease (80-85% are incurable), causing nearly 60,000 annual deaths from lung cancer. Early detection  \nthrough lung cancer screening (LCS) can result in curative therapies for earlier stages of lung cancer  \nand improved survival. Annual low-dose computerized tomography (LDCT) is the standard method for  \nLCS. Usually, high-risk populations (age>50 yr and >20 pack-years of smoking) are considered for LCS,  \nbut even such focused screening may be challenging in resource-limited countries like India. However,  \ndeveloping a smart LCS programme with high yield may be possible by leveraging demographic and  \ngenomic data, use of smart tools, and judicious use of blood-based biomarkers. Developing this model  \nover the next several years will facilitate a structured cancer screening programme for populations at  \nthe highest risk of lung cancer. In this paper, we discuss the demographics of lung cancer in India and  \nits relation to smoking patterns. Further, we elaborate on the potential applications and challenges of  \nbringing a smart approach to LCS in high-risk populations in India.  \nKey words Artificial intelligence-biomarkers-high-risk population-India-low-dose CT scans-lung cancer-screening  \nLung cancer is the leading cause of cancer mortality across the globe and is primarily related to tobacco smoking. However, non-smoking lung cancers have increased in the last two decades, possibly due to air pollution1,2 . Large trials have shown that lung cancer screening (LCS) can reduce mortality in highrisk populations of smokers. Low-dose computerized tomography (LDCT)-based screening and smoking cessation counselling form the basis of LCS recommendations in the United States, Canada, parts  \nof Europe, Japan, and South Korea. Other nations, such as China and India, despite having the highest burdens, are yet to adopt LDCT for LCS. The number of new cancer cases among adults aged >60 is expected to increase by 75.2 per cent and deaths by 82.8 per cent by 20403.  \nThis manuscript attempts to define the burden of lung cancer in India and outline challenges in implementing a population-wide LCS programme.  \n© 2024 Indian Journal of Medical Research, published by Scientific Scholar for Director-General, Indian Council of Medical Research  \nThis open access publication is protected under CC-BY-NC-SA 4.0  \n562 INDIAN J MED RES, DECEMBER 2024  \nUnlike earlier reviews, which focus on summarizing the challenges, we delve into potential solutions for implementing an LCS programme. Populationlevel data, smart (artificial intelligence (AI)-based) tools, and point-of-care blood-based biomarkers that inform LDCT screening may result in a leaner yet comprehensive LCS programme.  \nThe problem of lung cancer in India  \nLung cancer is the most common cancer among Indian males, and the number of cases in India is expected to rise from 63,807 in 2015 to 81,219 cases in 20254 and it accounts for eight per cent of cancerrelate","cbCailipf41GabJ6","https://ap.wps.com/l/cbCailipf41GabJ6","pdf",350728,"English","# Introduction\n## Disease burden and rationale for early detection\n# Lung cancer screening evidence and current approaches\n## LDCT-based recommendations and gaps in adoption\n# The problem of lung cancer in India\n## Incidence, mortality, regional variation, and smoking prevalence\n# Arguments against lung cancer screening in India\n## Key concerns and limitations in implementation\n# Smart tools and biomarkers for future screening\n## Potential solutions and expected challenges","[{\"question\":\"Why is lung cancer screening important in India?\",\"answer\":\"Most patients in India present with advanced disease and have high mortality. Early detection through lung cancer screening can enable curative therapy for earlier stages and improve survival.\"},{\"question\":\"What is the standard method for lung cancer screening mentioned in the review?\",\"answer\":\"Annual low-dose computerized tomography (LDCT) is described as the standard method for lung cancer screening.\"},{\"question\":\"How can smart tools and biomarkers improve lung cancer screening?\",\"answer\":\"The review suggests that leveraging demographic and genomic data, using smart tools, and applying blood-based biomarkers could help identify individuals at highest risk and make screening programs more efficient in resource-limited settings.\"}]","Lung cancer screening in India: Preparing for the future using smart tools & biomarkers to identify highest risk individuals | PDF",1790024988,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3e9e16f52773a34dd801d0af4268745.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74af0d7af1eddb38f37b5fc659130e52.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a884836b86edddc7ff2b73b0c0fd232e.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/322301ae9d21290d0e67450cbfaa7ca4.webp",980,1268]